Disclosed is a tablet composition comprising: a) 48% to 55% by weight of dalcetrapib (S-[2-([[1-(2-ethylbutyl)-cyclohexyl]-carbonyl]amino)phenyl] 2-methylpropanethioate)； b) 24% to 26% by weight of microcrystalline cellulose； c) 11% to 12% by weight of micronised crospovidone； d) 4% to 5% by weight of hydroxypropylmethyl cellulose； and e) 4% to 6% by weight of croscarmellose sodium. Also disclosed is a process for the preparation of a dalcetrapib composition comprising the following steps: a) mixing and granulating dalcetrapib, crospovidone micronized, microcrystalline cellulose, croscarmellose sodium and hydroxypropyl methylcellulose； b) spraying up to 0.5% by weight of hydroxypropyl methylcellulose in water or in 10% - 30% ethanol by weight/70% - 90% water by weight, onto the granulates obtained according to step a)； c) drying the granulates； and d) blending microcrystalline cellulose, colloidal silicon dioxide and sodium stearylfumarate with the dry granulates obtained according to step c).
